SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3207REGENERON ANNOUNCES U.S. GOVERNMENT AGREEMENT TO PURCHASE ADDITIONAL COVID-19 ANBiotechwantabe11/12/2021
3206Didn't they win the court case with REGN ?nigel bates-1/12/2021
3205Since Kymab stole REGN technology, will Sanofi owe royalties to regeneron?CuttingEdge Bio-1/12/2021
3204PARIS and CAMBRIDGE, UK– January 11, 2021 – Sanofi and Kymab, a clinical-stage bnigel bates-1/11/2021
3203Probably. One of the benefits of socialised medicine is the ability to run more nigel bates-1/11/2021
3202Indeed, curious will this restart efforts to use either of these? Will these rFelix B-1/10/2021
3201Whoa. SurprisingCuttingEdge Bio-1/10/2021
3200Allocation of Casirivimab/Imdevimab by Jurisdiction CA New cases 7 day average Biotechwantabe-1/10/2021
3199From the same preprint: Compared with control, median adjusted odds ratios for hA.J. Mullen-1/9/2021
3198Thanks for that. My immediate response was that 8.5% was better than nothing buA.J. Mullen11/9/2021
3197Kevzara works on severe patients Treating critically ill COVID-19 patients witBiotechwantabe-1/8/2021
3196jp Morgan Alnylam 8:20am Regeneron 8:20am Now how do I decide which to view livBiotechwantabe-1/8/2021
3195Regeneron Statement on Preliminary Injunction of the Most Favored Nation RuleBiotechwantabe-1/1/2021
3194investor.regeneron.com US hospitalized trial going slowly. - good results. TheBiotechwantabe-12/29/2020
3193One does one determine when to does on PRN? I assume some it's some visual Felix B-12/21/2020
3192They used PRN dosing with bispecific to demonstrate that pidgeon holing Eylea paCuttingEdge Bio-12/21/2020
3191Thanks for clarifying as its been sometime since that study read out. I guess wFelix B-12/21/2020
3190That's not really true. They tried and failed to show superiority in BCVA. CuttingEdge Bio-12/21/2020
3189Curious why this showed NI when Regeneron's previous combo (two single mAbs)Felix B-12/21/2020
3188Roche’s_Faricimab_dosed_q8w_shows_NI_to_Eylea_in DME: roche.com Faricimab isDewDiligence_on_SI-12/21/2020
3187Check out this youtube video that explains trading biotech stocks with decent stBiopharmainvestor-12/20/2020
3186almanac.upenn.edu It baffles me that scientists can create these great technoloBiotechwantabe-12/17/2020
3185NASH genetic target sound good. Hope they can quickly conduce and produce POC daMiljenko Zuanic-12/17/2020
3184On a positive note, alnylam/ regeneron collaboration moving along. Keeping fiBiotechwantabe-12/17/2020
3183There is more than enough patients; so it’s ineffective process. Maybe ship dosBiotechwantabe-12/16/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News